PolyPid Ltd PYPD
News
PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
PolyPid Announces Participation in Upcoming Fall Investor Conferences
